Core Insights - Nexxen has launched a new feature in its advertising platform, Nexxen Health, which integrates measurement and optimization for health and pharmaceutical advertisers, enhancing data-driven advertising campaigns while ensuring privacy compliance [1][6] - The introduction of Auto Allocate in Nexxen DSP allows for real-time audience targeting and ad spend optimization, addressing previous challenges faced by health marketers [2][3] Group 1: Product Features - Nexxen Health now includes real-world health intelligence through expanded integration with PurpleLab, improving accuracy and verified outcome performance for advertisers [1][5] - Auto Allocate utilizes real-time signals to identify high-quality audiences, enabling dynamic budget optimization based on strategic audience quality and verified patient metrics [2][3] - The platform supports the entire pharmaceutical campaign lifecycle by combining targeting, activation, optimization, and measurement in one unified workflow [5][6] Group 2: Industry Impact - The integration of PurpleLab's analytics into Nexxen DSP allows advertisers to act on clinically grounded signals, enhancing data integrity and accountability in health advertising [5] - The new features are designed to help health and pharmaceutical advertisers reach interested audiences in a compliant manner while providing insights into campaign effectiveness [6]